Closed loop
The lab is a teacher, not just a judge.
Most pharma pipelines treat the lab as a one-way validator. Ours treats every assay readout as training signal - the next batch of predictions is informed by the last batch of results.
- Ex-vivo readouts include cancer-cell death and tumor-volume reduction, including Day 7 measurements.
- Healthy-cell controls run in parallel for selectivity scoring.
- Readouts update the model's priors before the next prediction batch.
What we measure
Apoptosis selectivity.
30+
Cancer types tested in our ex vivo program
100%
Cancer cell death observed in selected models
~0%
Cell death on healthy fibroblasts in same conditions